4-81110486-C-CGCTCTTAAAGTATATACACTTTATCACTAGTTAGGTTATTTTTGCATTTCTCTGAAGAGGTGGCTG
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PVS1PM2PP5_Moderate
The NM_006259.3(PRKG2):c.1901_1902insCAGCCACCTCTTCAGAGAAATGCAAAAATAACCTAACTAGTGATAAAGTGTATATACTTTAAGAGC(p.Trp634delinsCysSerHisLeuPheArgGluMetGlnLysTer) variant causes a stop gained, protein altering change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Pathogenic (★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_006259.3 stop_gained, protein_altering
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 12 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PRKG2 | NM_006259.3 | c.1901_1902insCAGCCACCTCTTCAGAGAAATGCAAAAATAACCTAACTAGTGATAAAGTGTATATACTTTAAGAGC | p.Trp634delinsCysSerHisLeuPheArgGluMetGlnLysTer | stop_gained, protein_altering_variant | 15/19 | ENST00000264399.6 | NP_006250.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PRKG2 | ENST00000264399.6 | c.1901_1902insCAGCCACCTCTTCAGAGAAATGCAAAAATAACCTAACTAGTGATAAAGTGTATATACTTTAAGAGC | p.Trp634delinsCysSerHisLeuPheArgGluMetGlnLysTer | stop_gained, protein_altering_variant | 15/19 | 5 | NM_006259.3 | ENSP00000264399 | P1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jul 05, 2022 | This sequence change creates a premature translational stop signal (p.Trp634delinsCysSerHisLeuPheArgGluMetGlnLys*) in the PRKG2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in PRKG2 are known to be pathogenic (PMID: 19149413, 33106379). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with PRKG2-related conditions. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.